CORRGENE
CorrGene is an innovative company focusing on the research and development and production of new anti-cancer drugs and rare diseases with gene editing technology and cell therapy. The company was established by a group of cell and gene therapy experts, virologists, oncologists, hematologists and biopharmaceutical industry veterans. CorrGene was established in January, 2022 in Jiangsu, China.
CORRGENE
Industry:
Biotechnology Health Care Medical
Founded:
2022-01-01
Address:
Nanjing, Jiangsu, China
Country:
China
Status:
Active
Total Funding:
15.7 M USD
Investors List
Wuxi Capital
Wuxi Capital investment in Seed Round - CorrGene
Med-Fine Capital
Med-Fine Capital investment in Seed Round - CorrGene
Golden Capital Partners
Golden Capital Partners investment in Seed Round - CorrGene